


























![]()
Q1: 2026-05-05 Earnings Summary
EPS of $0.05 beats by $0.09
|
Revenue of
$1.38B
(0.95% Y/Y)
misses by $17.97M
The Chemours Company (CC) Q1 2026 Earnings Call May 6, 2026 8:00 AM EDT
Company Participants
Brandon Ontjes - Vice President of Investor Relations
Denise Dignam - President, CEO & Director
Shane Hostetter - Senior VP & CFO
Conference Call Participants
Joshua Spector - UBS Investment Bank, Research Division
John McNulty - BMO Capital Markets Equity Research
Hassan Ahmed - Alembic Global Advisors
Arun Viswanathan - RBC Capital Markets, Research Division
Peter Osterland - Truist Securities, Inc., Research Division
Patrick Fischer - Goldman Sachs Group, Inc., Research Division
Daniel Rizzo - Jefferies LLC, Research Division
Vincent Andrews - Morgan Stanley, Research Division
Presentation
Operator
Good morning. My name is Michelle, and I will be your conference operator today. I would like to welcome everyone to the Chemours Company First Quarter 2026 Results Conference Call. [Operator Instructions] I would like to remind everyone that this conference call is being recorded.
I would now like to hand the conference over to Brandon Ontjes, Vice President, Head of Strategy and Investor Relations for Chemours. You may begin your conference.
Brandon Ontjes
Vice President of Investor Relations
Good morning, everybody. Welcome to the Chemours Company First Quarter 2026 Earnings Conference Call. I'm joined today by Denise Dignam, Chemours' President and Chief Executive Officer; and our Senior Vice President and Chief Financial Officer, Shane Hostetter.
Before we start, I would like to remind you that comments made on this call as well as in the supplemental information provided on our website contain forward-looking statements that involve risks and uncertainties as described in Chemours' SEC filings. These forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events that may not be realized. Actual results may differ, and Chemours undertakes no duty to update any forward-looking statements as a result of future developments or new information. During the course of this
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。